A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

Clinical trial NCT05520177 · COMPLETED

Trial details

NCT number: NCT05520177
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Branch Retinal Vein Occlusion

Start date: 2022-12-27
Primary completion: 2024-09-23
Enrollment: 351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.